MPH Health Care AG operates in the healthcare market in Germany.
Mediocre balance sheet and slightly overvalued.
Share Price & News
How has MPH Health Care's share price performed over time and what events caused price changes?
Latest Share Price and Events
7 Day Return
1 Year Return
Return vs Industry: 93M underperformed the German Pharmaceuticals industry which returned 2.9% over the past year.
Return vs Market: 93M underperformed the German Market which returned 7.2% over the past year.
Price Volatility Vs. Market
How volatile is MPH Health Care's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is MPH Health Care undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 93M (€3.73) is trading below our estimate of fair value (€4.33)
Significantly Below Fair Value: 93M is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: 93M is unprofitable, so we can't compare its PE Ratio to the Pharmaceuticals industry average.
PE vs Market: 93M is unprofitable, so we can't compare its PE Ratio to the German market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 93M's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 93M is good value based on its PB Ratio (0.6x) compared to the DE Pharmaceuticals industry average (2x).
How is MPH Health Care forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 93M is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 93M is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 93M is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 93M's revenue (50.6% per year) is forecast to grow faster than the German market (5% per year).
High Growth Revenue: 93M's revenue (50.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 93M's Return on Equity is forecast to be high in 3 years time
How has MPH Health Care performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: 93M is unprofitable, but has reduced losses over the past 5 years at a rate of 3.8% per year.
Accelerating Growth: Unable to compare 93M's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 93M is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (1.9%).
Return on Equity
High ROE: 93M has a negative Return on Equity (-14.8%), as it is currently unprofitable.
Return on Assets
ROA vs Industry: 93M is currently unprofitable, so its Return on Assets is negative.
Return on Capital Employed
ROCE Improving: 93M is currently unprofitable, so its Return on Capital Employed is negative.
How is MPH Health Care's financial position?
Financial Position Analysis
Short Term Liabilities: 93M's short term assets (€9.9M) exceeds its short term liabilities (€8.8M)
Long Term Liabilities: 93M's short term assets (9.9M) do not cover its long term liabilities (16.4M)
Debt to Equity History and Analysis
Debt Level: 93M's debt to equity ratio (5.6%) is considered satisfactory
Reducing Debt: 93M's debt to equity ratio has reduced from 41.6% to 5.6% over the past 5 years.
Debt Coverage: 93M's debt is not well covered by operating cash flow (5%).
Interest Coverage: Insufficient data to determine if 93M's interest payments on its debt are well covered by EBIT.
Inventory Level: 93M has a low level of unsold assets or inventory.
Debt Coverage by Assets: 93M's debt is not covered by short term assets (assets are 0.7x debt).
What is MPH Health Care's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: 93M's dividend (5.36%) is higher than the bottom 25% of dividend payers in the German market (1.48%).
High Dividend: 93M's dividend (5.36%) is in the top 25% of dividend payers in the German market (3.83%)
Stable Dividend: Whilst dividend payments have been stable, 93M has been paying a dividend for less than 10 years.
Growing Dividend: 93M's dividend payments have increased, but the company has only paid a dividend for 4 years.
Current Payout to Shareholders
Dividend Coverage: 93M is paying a dividend but the company is unprofitable.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
What is the CEO of MPH Health Care's salary, the management and board of directors tenure and is there insider trading?
Patrick Brenske 0
Mr. Patrick Brenske has been the Chief Executive Officer of MPH Mittelständische Pharma Holding AG since January 23, 2009 and has been its Member of Management Board since 2009. Mr. Brenske serves as Chief ...
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
CEO & Member of Management Board
- Tenure: 10.8yrs
Ulrich Wandschneider (58yo)
Deputy Chairman of Supervisory Board
- Tenure: 2.1yrs
Sabine Meck (64yo)
Member of Supervisory Board
- Tenure: 0yrs
Andrea Grosse (54yo)
Chairwoman of Supervisory Board
- Tenure: 9.6yrs
MPH Health Care AG's company bio, employee growth, exchange listings and data sources
- Name: MPH Health Care AG
- Ticker: 93M
- Exchange: XTRA
- Founded: 2008
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: €159.696m
- Shares outstanding: 42.81m
- Website: https://www.mph-ag.de
Number of Employees
- MPH Health Care AG
- Grünauer Strasse 5
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|93M||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Sep 2014|
|93M||XTRA (XETRA Trading Platform)||Yes||Common Stock||DE||EUR||Sep 2014|
|93MD||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Stock||GB||EUR||Sep 2014|
|0W1Q||LSE (London Stock Exchange)||Yes||Common Stock||GB||EUR||Sep 2014|
MPH Health Care AG operates in the healthcare market in Germany. It produces medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treat ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2019/10/22 21:52|
|End of Day Share Price||2019/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.